These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2787895)

  • 21. Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection.
    Tóth FD; Szabó B; Ujhelyi E; Pálóczi K; Horváth A; Füst G; Kiss J; Bánhegyi D; Hollán SR
    AIDS; 1991 Mar; 5(3):263-8. PubMed ID: 1676275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralizing antibodies and antigens in AIDS.
    Norley SG; Kurth R
    Infection; 1991; 19 Suppl 2():S83-8. PubMed ID: 1707855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunology and the elusive AIDS vaccine.
    Virgin HW; Walker BD
    Nature; 2010 Mar; 464(7286):224-31. PubMed ID: 20220841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the CD4 antigen in HIV infection and immune pathogenesis.
    Sattentau QJ
    AIDS; 1988; 2 Suppl 1():S11-6. PubMed ID: 2852500
    [No Abstract]   [Full Text] [Related]  

  • 25. AIDS vaccine development.
    Lévy JP
    Science; 1998 May; 280(5365):806-7. PubMed ID: 9599149
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion.
    Boyer V; Desgranges C; Trabaud MA; Fischer E; Kazatchkine MD
    J Exp Med; 1991 May; 173(5):1151-8. PubMed ID: 1827139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopathogenesis of HIV infection.
    Wigzell H
    J Acquir Immune Defic Syndr (1988); 1988; 1(6):559-65. PubMed ID: 2976089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HIV-antibodies in tears of patients with AIDS.
    Liotet S; Hartmann C; Batellier L; Chaumeil C; Frottier J
    Fortschr Ophthalmol; 1987; 84(4):340-1. PubMed ID: 3478293
    [No Abstract]   [Full Text] [Related]  

  • 29. Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex.
    Archibald DW; Barr CE; Torosian JP; McLane MF; Essex M
    J Infect Dis; 1987 Apr; 155(4):793-6. PubMed ID: 3469280
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel vaccination and antireceptor strategies against HIV.
    Laurence J
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):175-81. PubMed ID: 2183853
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibodies against AIDS proteins.
    Devash Y; Reagan K; Wood D; Turner J; Parrington M; Kang CY
    Nature; 1990 Jun; 345(6276):581. PubMed ID: 2190091
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.
    Goudsmit J; Lange JM; Paul DA; Dawson GJ
    J Infect Dis; 1987 Mar; 155(3):558-60. PubMed ID: 3468176
    [No Abstract]   [Full Text] [Related]  

  • 33. Persistence of anti-HIV p24 antibodies in African AIDS patient.
    van den Akker R; Bouman-van Engelen CA; de Jong JC; Dolmans WM; van Loon AM; Mulder DW; Shao JF
    AIDS; 1988 Feb; 2(1):62-3. PubMed ID: 3129000
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunology of infection with the human immunodeficiency virus (HIV). A view from the III International Conference on AIDS.
    Koenig S; Rosenberg ZF
    Ann Intern Med; 1987 Sep; 107(3):409-11. PubMed ID: 3304052
    [No Abstract]   [Full Text] [Related]  

  • 35. Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group.
    Montefiori DC; Lefkowitz LB; Keller RE; Holmberg V; Sandstrom E; Phair JP
    AIDS; 1991 May; 5(5):513-7. PubMed ID: 1863402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
    Bender BS; Davidson BL; Kline R; Brown C; Quinn TC
    Rev Infect Dis; 1988; 10(6):1142-54. PubMed ID: 3206059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?
    Robinson WE; Montefiori DC; Mitchell WM
    Lancet; 1988 Apr; 1(8589):830-1. PubMed ID: 2895350
    [No Abstract]   [Full Text] [Related]  

  • 38. Complement receptors: another port of entry for HIV.
    Soelder BM; Reisinger EC; Koefler D; Bitterlich G; Wachter H; Dierich MP
    Lancet; 1989 Jul; 2(8657):271-2. PubMed ID: 2569072
    [No Abstract]   [Full Text] [Related]  

  • 39. Losing AIDS antibodies.
    Barnes DM
    Science; 1988 Jun; 240(4858):1407. PubMed ID: 3163850
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV mutation rate.
    Nowak M
    Nature; 1990 Oct; 347(6293):522. PubMed ID: 2215679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.